PF-AtlasClinical Trials › NCT06690749

Using Skin Blood Flow to Measure the Effect of Different Doses of Negative Pressure Therapy

Negative pressure therapy, NPT · Not specified

Registry ID
NCT06690749
Phase
Not specified
Status
Completed
Drug / intervention
Negative pressure therapy, NPT
Sponsor
Asia University
Start
2022-05-11
Enrollment
36
Locations
1

About this trial

Introduction. Skin blood flow (SBF) is crucial for transporting nutrients during healing to treat scarring. Negative pressure therapy (NPT) is a promising option to enhance SBF. However, it is unclear what dosage of NPT is most effective in treating scars. This study compared NPT dosages of -105 mmHg, -125 mmHg, and -145 mmHg to assess the impact of NPT treatment on SBF in scar tissue and the correlation of NPT. If participants experience any symptoms of discomfort, NPT can be discontinued immediately. 36 scarred subjects were recruited to assess the efficacy of various NPT interventions. SBF applications are defined as perfusion levels instantly affecting NPT, and termination is defined as SBF after NPT. The study runs from May 11, 2022, to May 11, 2023, at Asia University Hospital. This study was funded by the National Science and Technology Council, Taiwan (NSTC 112-2221-E-468-004) The main contact was Chi-Wen Lung, the person in charge of a college or university department of Product Design, Asia University, Taichung 413305, Taiwan.Email address: cwlung@asia.edu.tw

View NCT06690749 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT06690749 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.